An IoT-based Drug Delivery System for Refractory Epilepsy

Epilepsy affects approximately 1% of the worlds population and is medically refractory in a large fraction of these patients necessitating innovative solutions for seizure control. Here, we describe a unified drug delivery system within the IoT framework which provides drug injection upon seizure detection for seizure control. An electromagnetically actuated valveless micropump, with a diaphragm composed of Polydimethylsiloxane (PDMS), was used for drug delivery. A prototype of the solution was implemented using Simulink
^®
and ThingSpeak™. Simulation results demonstrate that the proposed system reduces power consumption considerably (10-30%) while maintaining high accuracy.